Maxion Therapeutics
Developer of a novel platform designed to generate antibody-like therapeutics to solve ion channel and GPCR-driven diseases. The company combines mini-proteins found in venom and other sources called ...
Valuation
$110.6M
Market implied
Share Price
N/A
Total Raised
$105.1M
Last Round
N/A
Investors
+8 other investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details
Sector
Healthcare
Headquarters
Cambridge, United Kingdom
Founded
2020
Employees
50
Website
maxiontherapeutics.com